PAK5 and neoplasm: Consistent with our in vitro results, specific overexpression of PAK5 significantly alleviated the inhibitory effects of trastuzumab on SK-BR-3 tumor growth, evidenced by a significant increment of tumor size and weight as compared to the FLAG control (Fig. 7A, B).